GENBYTE TECHNOLOGY INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.16 CNY | -1.32% |
|
-0.12% | -6.58% |
| May. 08 | Genbyte Technology's Product Gets Certification From TÜV Rheinland | MT |
| May. 06 | Genbyte Obtains ISO Certification for Medical Device Quality Management System | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 4,569 | 4,651 | 4,630 |
| Enterprise Value (EV) 1 | 3,810 | 3,944 | 3,632 |
| P/E ratio | 19.8 x | 22.1 x | 27.6 x |
| Yield | 0.72% | 0.72% | 0.71% |
| Capitalization / Revenue | 4.6 x | 3.53 x | 4.44 x |
| EV / Revenue | 3.83 x | 2.99 x | 3.49 x |
| EV / EBITDA | 17.9 x | 16.6 x | 25.6 x |
| EV / FCF | 57.4 x | -57.4 x | 13.8 x |
| FCF Yield | 1.74% | -1.74% | 7.25% |
| Price to Book | 4.41 x | 3.73 x | 3.31 x |
| Nbr of stocks (in thousands) | 109,600 | 111,003 | 109,687 |
| Reference price 2 | 41.69 | 41.90 | 42.21 |
| Announcement Date | 4/19/21 | 4/10/22 | 3/29/23 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 475.8 | 567.6 | 696.5 | 994.2 | 1,317 | 1,042 |
| EBITDA 1 | 105.5 | 94.58 | 131.1 | 212.6 | 237.2 | 142 |
| EBIT 1 | 102.7 | 91.67 | 124.2 | 204.7 | 228.1 | 129.2 |
| Operating Margin | 21.6% | 16.15% | 17.84% | 20.59% | 17.32% | 12.39% |
| Earnings before Tax (EBT) 1 | 101.1 | 98.7 | 132.7 | 200.3 | 243.6 | 193 |
| Net income 1 | 86.85 | 86.22 | 115.8 | 173.7 | 210.1 | 170.6 |
| Net margin | 18.26% | 15.19% | 16.62% | 17.47% | 15.95% | 16.37% |
| EPS 2 | 1.057 | 1.049 | 1.410 | 2.110 | 1.900 | 1.530 |
| Free Cash Flow 1 | -94.01 | 35.4 | 80.62 | 66.33 | -68.7 | 263.3 |
| FCF margin | -19.76% | 6.24% | 11.57% | 6.67% | -5.22% | 25.27% |
| FCF Conversion (EBITDA) | - | 37.43% | 61.47% | 31.19% | - | 185.42% |
| FCF Conversion (Net income) | - | 41.05% | 69.65% | 38.2% | - | 154.33% |
| Dividend per Share | - | 0.7500 | 1.120 | 0.3000 | 0.3000 | 0.3000 |
| Announcement Date | 6/21/19 | 6/21/19 | 12/13/20 | 4/19/21 | 4/10/22 | 3/29/23 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 74.9 | 121 | 181 | 759 | 707 | 998 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -94 | 35.4 | 80.6 | 66.3 | -68.7 | 263 |
| ROE (net income / shareholders' equity) | 37.7% | 27.6% | 31.4% | 24.3% | 18.6% | 13% |
| ROA (Net income/ Total Assets) | 16.2% | 13.2% | 14.6% | 12.7% | 9.17% | 4.63% |
| Assets 1 | 537.4 | 651 | 794.6 | 1,365 | 2,291 | 3,682 |
| Book Value Per Share 2 | 3.420 | 4.180 | 4.810 | 9.450 | 11.20 | 12.80 |
| Cash Flow per Share 2 | 0.9100 | 1.480 | 2.200 | 6.930 | 2.460 | 6.720 |
| Capex 1 | 13.1 | 15.2 | 16.3 | 24.3 | 30.8 | 95.1 |
| Capex / Sales | 2.76% | 2.68% | 2.33% | 2.44% | 2.34% | 9.12% |
| Announcement Date | 6/21/19 | 6/21/19 | 12/13/20 | 4/19/21 | 4/10/22 | 3/29/23 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -6.58% | 627M | |
| +10.88% | 159B | |
| +28.73% | 141B | |
| +37.27% | 132B | |
| +18.72% | 66.09B | |
| +3.58% | 39.54B | |
| +98.63% | 35.71B | |
| +5.58% | 31.73B | |
| -11.88% | 31.19B | |
| +9.83% | 29.1B |
- Stock Market
- Equities
- 003028 Stock
- Financials Genbyte Technology Inc.
